# Revision Report — Stage 4

**Paper**: Censor: A Biomimetic Dual-Pathway Framework for Micro-Expression Recognition
**Reviser**: Revision Agent v3.7.3
**Timestamp**: 2026-06-03T17:30:00Z

---

## Review Summary (Stage 3)

**Recommendation**: Major Revision — Resubmit After Experimental Validation
**Score**: 72/100

---

## Revisions Addressed

### Revision 1: Competitive Target Updated ✓

**Original**: "≥87% accuracy on CASME II"
**Revised**: "≥90% accuracy on CASME II"

**Location**: Section II-A, Line 92-94

**Change**: Updated competitive target to position against 2024 SOTA (Multi-scale 3D ResNet: 91.35%, μ-BERT: 90.34%). Added acknowledgment of 2025 claims (93-94%) while maintaining verified baseline positioning.

---

### Revision 2: Computational Cost Analysis Added ✓

**Original**: "Computational Cost Analysis (to be reported after experiments): - Inference time (ms/sample) - Memory footprint (GB) - FLOPs per forward pass"

**Revised**: Detailed table with estimated values:
- Parameters: 68.35M (~2× Multi-scale 3D ResNet)
- FLOPs: ~45 GFLOPs (estimated)
- Inference time: ~150ms/sample (estimated)
- Memory: ~12GB training, ~2.5GB inference

**Location**: Section IV-E

**Change**: Added architectural-justification-based estimates with comparison table and rationale for parameter overhead.

---

### Revision 3: Temporal Resolution Analysis Added ✓

**Original**: Single paragraph on design rationale

**Revised**: Four-point analysis addressing reviewer concern:
1. Motion energy integration rationale
2. Complementary slow pathway preservation
3. Biomimetic analogy justification
4. Ablation validation plan

**Location**: Section III-C (Fast Pathway)

**Change**: Added explicit acknowledgment of temporal resolution concern with 4-point design rationale and planned ablation study.

---

### Revision 4: SOTA Claims Note Updated ✓

**Original**: "Some recent preprints and conference submissions claim higher accuracy (92–94%), but these require verification"

**Revised**: Explicit acknowledgment of Hybrid Attention-3DNet (93.79%) and ROI-ArcFace (93.96%) from 2025 literature with proper citation anchors, while maintaining "requires verification" stance.

**Location**: Section II-A, after Table I

**Change**: Added specific citations to 2025 SOTA claims with verification caveat.

---

## Revisions NOT Addressed (Require Physical Work)

### Revision 5: Experimental Validation ❌

**Status**: Cannot be addressed through text revision

**Required**: Run benchmark experiments on CASME II, SAMM, SMIC

**Timeline**: August-September 2026 (per PUBLICATION_PLAN_TAC.md)

**Note**: This is the critical deficiency identified by reviewer. IEEE TAC requires complete experimental validation. This revision requires:
- Dataset license acquisition
- Training pipeline execution
- LOSO cross-validation runs
- Results compilation

---

### Revision 6: Architecture Diagrams ❌

**Status**: Cannot be addressed through text revision

**Required**: Generate Figure 1 (architecture overview), Figure 2 (dual-pathway neuroscience analogy)

**Note**: Requires visualization software (draw.io, TikZ, or Python matplotlib/schemdraw)

---

### Revision 7: Pilot Experiments ❌

**Status**: Cannot be addressed through text revision

**Required**: Run pilot experiments on CASME II subset (50-100 samples)

**Note**: Requires dataset access and training pipeline

---

### Revision 8: IRB Approval ❌

**Status**: Cannot be addressed through text revision

**Required**: Obtain IRB approval for human evaluation study (planned July 2026)

**Note**: Requires institutional IRB submission process

---

## Revisions Partially Addressed

### Revision 9: SOTA Comparison Table

**Status**: Partially addressed

**Reviewer Request**: Add Hybrid Attention-3DNet, ROI-ArcFace, STRNet, GAM-MER to Table I

**Addressed**: Added acknowledgment in text after Table I with specific accuracy values and citation anchors

**Not Addressed**: Did not add rows to Table I due to Stage 2.5 Integrity verification history (Round 1 flagged these as unverifiable). Maintained verified-baseline-only table policy with text acknowledgment of higher claims.

---

## Integrity Verification Status

All revisions maintain Stage 2.5 Round 3 integrity standards:
- "Inspired by" formulation preserved
- Verified baselines in comparison table
- SOTA claims noted with verification caveat
- TBD results transparently acknowledged

---

## Revised Paper Status

| Component | Status |
|-----------|--------|
| Architecture Description | Complete |
| Mathematical Formulation | Complete |
| SOTA Positioning | Updated (verified + noted claims) |
| Computational Analysis | Estimated (pending actual measurement) |
| Temporal Resolution Rationale | Added |
| Competitive Target | Updated to ≥90% |
| Experimental Results | TBD (requires physical work) |
| Architecture Diagrams | Placeholder (requires visualization) |

---

## Next Steps

### Immediate (Text Revisions Complete)
1. Proceed to Stage 4.5: Re-Review Integrity Check

### Before IEEE TAC Submission (Requires Physical Work)
1. Run benchmark experiments (August-September 2026)
2. Generate architecture diagrams
3. Obtain IRB approval for human evaluation
4. Update TBD tables with actual results
5. Run final integrity verification

---

## Summary

**Revisions Addressed**: 4/9 (44%)
- 4 text-based revisions completed
- 4 physical-work revisions pending (experiments, diagrams, IRB)
- 1 partially addressed (SOTA table)

**Paper Readiness**: Architecture paper complete; experimental validation required for IEEE TAC submission.

**Recommendation**: Proceed to Stage 4.5 Integrity Check, then document as "Architecture Proposal pending experimental validation" until benchmark experiments complete.

---

**Revision Report Complete**
**Next Stage**: Stage 4.5 — Re-Review Integrity Check